Hospital Leadership and Management Support (HLMS) for Readiness Agency wide IDIQ (Single or MultiAward)
Archived on January 28, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM EST
- Posted
- January 8, 2026
- Notice type
- Combined Synopsis/Solicitation
- Agency
- Department of Health and Human ServicesINDIAN HEALTH SERVICE
Notice details
- Office
- DIVISION OF ACQUISITIONS POLICY HQ
- Place of performance
- Rockville, Maryland
- Last updated
- Nov 4, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75H70426R00003
- Notice ID
- 654156629ab441109ce7526c839eb5d4
Description
SOLICITATION UPDATE 1-8-2026
Amendment 004
The purpose of this amendment is to respond to offeror questions. See updated Q&A attachment dated 1-8-2026. Relative to this amendment are the following revised documents:
1. RFP/1449 V3 Amd 4 Track Changes & Clean Version
2. Attachment 1: Pricing Schedule V3
3. Attachment 2: PWS_HLMS v3 Track Changes & Clean Version
4.Q_A 1.8.26
SOLICITATION UPDATE 1-6-2026
Amendment 003
The purpose of this amendment is to respond to offeror questions. See updated Q&A attachment dated 1-6-2026, which includes a response to question 35. The response date for Phase II Proposal Volumes (except Oral Presentations which is a later date) is updated to reflect January 13, 2026 at 5PM EST. NOTE: Phase I optional submissions are no longer being accepted. The government is revewing Phase I submissions and plans to send out advisory notices (as referenced in the RFP) to respondents on or around January 9, 2026.
SOLICITATION UPDATE 12-30-2025
Amendment 002
The purpose of this amendment is to respond to offeror questions. See updated Q&A attachment dated 12-30-25, which includes responses to questions 19 through 34.
SOLICITATION UPDATE 12-29-2025
Amendment 001
The purpose of this amendment is to respond to offeror questions, update the Request for Proposal (RFP) document, the Performance Work Statement (PWS), and the Pricing Schedule. In addition, the number of required site visits has been reduced from ten (10) facilities to five (5) facilities. See updated attachments for more details.
Attachments:
-
Q&A Excel document dated December 29, 2025
-
RFP – Track Changes and Clean Copy
-
PWS – Track Changes and Clean Copy
-
Attachment 1: Pricing Schedule, with changes highlighted
__________________________________________________________________________________________________
ORIGINAL POSTING
The purpose of this solicitation is to make a single or multiaward IDIQ contract that provides consultation and professional support services to federal Indian Health Service (IHS) healthcare facilities, with an emphasis on healthcare leadership, accreditation, and operational and financial management support.
This document provides for a dual purpose to advise offerors of a two-Phase solicitation process; Phase I is an Advisory Multistep Process and evaluation of responses from potential offerors pursuant to RFO FAR 15.101 (e). Phase II is the formal solicitation process and evaluation of offers pursuant to RFO FAR 12 in conjunction with source selection procedures in RFO FAR 15. Phase II includes an oral presentation. The purpose of the two-Phase acquisition is lower the barrier to entry for contractors and allow evaluators to notify contractors that their proposal is unlikely to garner award but allows them to continue competing if they choose. This gives contractors an opportunity to withdraw from competition before bearing the costs of a full proposal submission reducing risk, cost, and time for both the contractor and the government.
To submit questions for this soliciation please use the Q&A template.
Please see attachments for more details.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Files (21)
- Download
SF 1449_75H70426R00003 V3 Amd 4 Track Changes.docx
229 KBAdded in Combined Synopsis/Solicitation version 6Posted - Download
SF 1449_75H70426R00003 V3 Amd 4 Clean.docx
228 KBAdded in Combined Synopsis/Solicitation version 6Posted - Download
Attachment 2 - PWS_HLMS FINAL v3 Track Changes.docx
52 KBAdded in Combined Synopsis/Solicitation version 6Posted - Download
Attachment 2 - PWS_HLMS FINAL v3 Clean.docx
51 KBAdded in Combined Synopsis/Solicitation version 6Posted - Download
Attachment 1 - Pricing Schedule Final V3.xlsx
47 KBAdded in Combined Synopsis/Solicitation version 6Posted - Download
HLMS Q_A 1.8.26.xlsx
25 KBAdded in Combined Synopsis/Solicitation version 6Posted - Download
HLMS Q_A 1.6.26.xlsx
20 KBAdded in Combined Synopsis/Solicitation version 4Posted - Download
HLMS Q_A 12.30.25.xlsx
19 KBAdded in Combined Synopsis/Solicitation version 3Posted - Download
SF 1449_75H70426R00003 V2 Amd 2 Clean.pdf
1.1 MBAdded in Combined Synopsis/Solicitation version 2Posted - Download
SF 1449_75H70426R00003 V2 Amd 2 Track Changes.docx
231 KBAdded in Combined Synopsis/Solicitation version 2Posted - Download
Attachment 2 - PWS_HLMS FINAL v2 Clean.docx
52 KBAdded in Combined Synopsis/Solicitation version 2Posted - Download
Attachment 2 - PWS_HLMS FINAL v2 Track Changes.docx
55 KBAdded in Combined Synopsis/Solicitation version 2Posted - Download
HLMS Q_A 12.29.25.xlsx
15 KBAdded in Combined Synopsis/Solicitation version 2Posted - Download
Attachment 1 - Pricing Schedule Final V2.xlsx
46 KBAdded in Combined Synopsis/Solicitation version 2Posted - Download
HLMS Q_A Template.xlsx
8.9 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
SF 1449_75H70426R00003 SIGNED.pdf
1.2 MBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Attachment 3 - QASP.doc
370 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Attachment 5 - Past Performance Report - Short Form.docx
36 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Attachment 2 - PWS_HLMS FINAL.docx
56 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Attachment 1 - Pricing Schedule 12.22.25.xlsx
46 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Attachment 4 - Ordering Procedures.docx
19 KBAdded in Combined Synopsis/Solicitation version 1Posted
Lifecycle
- 1Version 1Combined Synopsis/SolicitationArchived
Hospital Leadership and Management Support (HLMS) for Readiness Agency wide IDIQ (Single or MultiAward)
- 2Version 2Combined Synopsis/SolicitationArchived
Hospital Leadership and Management Support (HLMS) for Readiness Agency wide IDIQ (Single or MultiAward)
- 3Version 3Combined Synopsis/SolicitationArchived
Hospital Leadership and Management Support (HLMS) for Readiness Agency wide IDIQ (Single or MultiAward)
- 4Version 4Combined Synopsis/SolicitationArchived
Hospital Leadership and Management Support (HLMS) for Readiness Agency wide IDIQ (Single or MultiAward)
- 6Version 6Combined Synopsis/SolicitationArchivedCurrent
Hospital Leadership and Management Support (HLMS) for Readiness Agency wide IDIQ (Single or MultiAward)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Attachment One: Presolicitation Notice | 68% | Pre-Solicitation | 11/30/2026 |
FOOD AND DRUG ADMINISTRATION (FDA) Regulatory Support Services BPA SOURCES SOUGHT NOTICE (SSN) Description The U.S. Food and Drug Administration's (FDA), Office of Acquisitions and Grants Services (OAGS), is conducting market research for obtaining Regulatory Support Services. THIS IS A SOURCES SOUGHT NOTICE (SSN) ONLY. This SSN is being issued in accordance with Federal Acquisition Regulation (FAR) Part 10, Market Research. It is for information, planning and market research purposes only and is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. The Government reserves the right to contact any of the respondents after the submission deadline if additional information is required. The purpose of this SSN is to identify and gain knowledge of potential business sources and small business sources that are capable of providing the full range of services described in this SSN and the attached Draft Statement of Work (SOW). Responses to this SSN will be utilized for a potential solicitation for an anticipated stand-alone BPA for Regulatory Support Services Program. The anticipated period of performance for this contract is a Fiscal Year 2027 award with a base year, plus four (4) option years), with a potential 6-month extension of services pursuant to FAR 52.217-8. Requested Information Interested parties are highly encouraged to respond to this SSN by providing the following information in their response: Completed Vendor Feedback Form – See attached Vendor Feedback Form If applicable, tracked changes/comments on draft SOW in MS Word format – See attached Draft SOW Capability Statement Responses shall be submitted via email with the subject line "Sources Sought Notice - FDA SSN: CTP-2027-136871” to the Contracting Officer, Nicholas Bisher (Nicholas.Bisher@fda.hhs.gov), no later than 5:00pm (Eastern) on November 24, 2026. Attachments Vendor Feedback Form Draft Statement of Work | 68% | Market Research | 11/24/2026 |
This is not a solicitation announcement. This is a Sources Sought Notice (SSN) only. This SSN is issued solely for market research and planning purposes – it does not constitute a Request for Quotation (RFQ) or a promise to issue an RFQ in the future. Further, the SSN does not commit the Government to contract for any supply or service whatsoever. The FDA is not seeking proposals and will not accept any unsolicited proposals. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this SSN; all costs associated with responding to this SSN will be solely at the expense of the interested respondents. Not responding to this SSN does not preclude participation in any future RFQ, if issued. The purpose of this SSN is to gain knowledge of potential qualified vendors, including large business sources, small business sources and their size classifications (i.e., HUBZone 8(a), 8(a), HUBZone, Service-Disabled Veteran-Owned, Veteran-Owned, Women-Owned Small Business, and Small Disadvantaged Business) relative to the North American Industry Classification System (NAICS) code. Responses to this SSN will be used by the Government to make appropriate determinations about potential sources. Project Title: FDA/CDRH Scientific Technical Capacity for Regulatory Review Background: To assist the U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) in fulfilling its mission, CDRH seeks expert consultants to assist CDRH’s Offices with regulatory review across the total product lifecycle. CDRH requires consultants that have skilled experience to assist with medical device regulatory review work and supporting scientific activities, such as research, cybersecurity and digital health consultations, regulatory consultations and auditing, and interacting with industry and patients. The CDRH requires consultants that have sufficient skilled capacity in many science, engineering, and clinical specialties, including Anesthesiology, Biology, Biomedical Engineering, Chemistry, Clinical laboratory testing, Computer Science and Engineering, Consumer Safety, Cybersecurity, Data Science, Dentistry, Digital Health, Epidemiology, Gastroenterology, General Engineering, Health Science, Infectious Diseases, Interdisciplinary Engineer/Scientist, Molecular testing, Neurology, Optics, Patient Engagement, Physics, Psychiatry, Public Health, Pulmonology, Reprocessing medical devices, Social Scientist, Software Engineering, Statistics and Biostatistics, Sterilization, Toxicology, Urology, Veterinary Medicine, and Virology. Objective: The primary objective of this effort is to provide the CDRH with a vehicle to acquire the support services of advanced professional and scientific consultants to assist CDRH’s Offices with regulatory review across the total product lifecycle, including the supporting scientific, engineering, clinical, and regulatory activities. The services provided will be critical scientific expertise and capacity in support for the evaluation of the continued performance, safety, and effectiveness, with respect to devices approved, cleared, licensed, or authorized for use for the treatment, prevention, or diagnosis of medical conditions by the FDA. Instructions for Responses to this SSN: Your responses to the questions provided below will assist the Government in selecting the appropriate acquisition method. Page limit: Maximum 15 pages (font size Times New Roman 11 or larger). In addition to responses to the below questions, each vendor responding to this SSN shall also fill out and provide responses to “Attachment B-Vendor Feedback Form.” The Vendor Feedback Form is not included in the 15-page limit. A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions or the Vendor Feedback Form). The anticipated period of performance consists of one (1) Base Year and four (4) Option Years. Responses to this SSN must include company name, address, point of contact, size of business pursuant to the NAICS code, and must respond to the following questions: Is your business a small business under the NAICS code? Does your firm qualify as a Small Disadvantaged Business? If disadvantaged, specify if your firm is certified under Section 8(a) of the Small Business Act? Are you considered a certified HUBZone firm? Are you considered Woman-Owned or operated business? Are you a certified Service-Disabled Veteran-Owned or Veteran-Owned business? Included is a draft Statement of Work that is inclusive of the anticipated Task Areas (“Attachment A-Draft Statement of Work”). All interested parties can provide written opinions/questions on the draft Statement of Work. All opinions/questions expressed should focus on strengthening the draft Statement of Work Tasks to ensure industry understands and comprehends the government’s requirements. Responses to this SSN shall be submitted via e-mail to Melinda Kim, Contract Specialist, at Melinda.Kim@fda.hhs.gov, (with a CC: to Nicholas Bisher, Contracting Officer, at Nicholas.Bisher@fda.hhs.gov), by 2:00 PM Eastern Standard Time on November 17, 2026. The subject line of the e-mail shall reference, “Vendor Response to SSN 75F40127Q00006.” After a review of the received responses, a formal solicitation may be published on SAM.gov or on GSA eBuy. No solicitation is currently available. This is not a request for quotation and in no way obligates the Government to award any contract. Responses to this SSN will not be considered adequate responses to the solicitation, a request to be added to a prospective offerors list, or a request to receive a copy of the solicitation. Attachments: Attachment A-Draft Statement of Work Attachment B-Vendor Feedback Form | 68% | Market Research | 11/17/2026 |
68% | Sole Source / J&A | Open | |
The Centers for Medicare and Medicaid Services seeks information from potential vendors regarding its the Qualified Independent Contractor (QIC) program. Please the attached documents for further details. ------------------------------------------------------------------------------------------------------------------------------------------- 10/19/26 - adding the Technical Questions workbook attachment referenced on page 7 of the RFI document | 65% | Special Notice | 11/05/2026 |
Additional Details
Solicitation Number
75H70426R00003
Archive Date
Jan 28, 2026
Office Address
ROCKVILLE, MD, 20857